CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPβ represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection

Journal of Experimental Medicine

Volumn 198, Issue 3, 2003, Pages 443-453

  Komuro, Iwao ^a,b   Yokota, Yasuko ^a   Yasuda, Sachiko ^a   Iwamoto, Aikichi ^b   Kagawa, Kiyoko S ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

C EBP ; CSF; Hck; HIV 1; Macrophages

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CCAAT ENHANCER BINDING PROTEIN BETA; COLONY STIMULATING FACTOR 1; HEMATOPOIETIC CELL KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN VARIANT; TRANSCRIPTION INITIATION SITE; VIRUS REPLICATION; VIRUS SURVIVAL;

CCAAT-ENHANCER-BINDING PROTEIN-BETA; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; VIRUS REPLICATION;

EID: 0041622820     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20022018     Document Type: Article

References (49)

1. Ghorpade, A., M.Q. Xia, B.T. Hyman, Y. Persidsky, A. Nukuna, P. Bock, M. Che, J. Limoges, H.E. Gendelman, and C.R. Mackay. 1998. Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol. 72: 3351-3361.
2. Lane, B.R., D.M. Markovitz, N.L. Woodford, R. Rochford, R.M. Strieter, and M.J. Coffey. 1999. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163:3653-3661.
3. Chun, T.W., L. Carruth, D. Finzi, X. Shen, J.A. Di-Giuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T.C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:183-188.
4. Li, S., J. Juarez, M. Alali, D. Dwyer, R. Collman, A. Cunningham, and H.M. Naif. 1999. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J. Virol. 73:9741-9755.
5. Hatch, W.C., A.R. Freedman, D.M. Boldt-Houle, J.E. Groopman, and E.F. Terwilliger. 1997. Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human alveolar macrophages. Blood. 89:3443-3450.
6. Orenstein, J.M., C. Fox, and S.M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science. 276:1857-1861.
7. Cavert, W., D.W. Notermans, K. Staskus, S.W. Wietgrefe, M. Zupancic, K. Gebhard, K. Henry, Z.Q. Zhang, R. Mills, H. McDade, et al. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [published erratum at 276:1321]. Science. 276:960-964.
8. Perelson, A.S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D.D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 387:188-191.
9. Orenstein, J.M., M. Feinberg, C. Yoder, L. Schrager, J.M. Mican, D.J. Schwartzentruber, R.T. Davey, Jr., R.E. Walker, J. Falloon, J.A. Kovacs, et al. 1999. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient. AIDS. 13:2219-2229.
10. Crowe, S.M., and S. Sonza. 2000. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68:345-350.
11. Mocsai, A., Z. Jakus, T. Vantus, G. Berton, C.A. Lowell, and E. Ligeti. 2000. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J. Immunol. 164:4321-4331.
12. Scholz, G., K. Cartledge, and A.R. Dunn. 2000. Hck enhances the adherence of lipopolysaccharide-stimulated macrophages via Cb1 and phosphatidylinositol 3- kinase. J. Biol. Chem. 275:14615-14623.
13. Saksela, K., G. Cheng, and D. Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
14. Moarefi, I., M. LaFevre-Bernt, F. Sicheri, M. Huse, C.H. Lee, J. Kuriyan, and W.T. Miller. 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 385:650-653.
15. Greenway, A.L., H. Dutartre, K. Allen, D.A. McPhee, D. Olive, and Y. Collette. 1999. Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation. J. Virol. 73:6152-6158.
16. Lang, S.M., A.J. Iafrate, C. Stahl-Hennig, E.M. Kuhn, T. Nisslein, F.J. Kaup, M. Haupt, G. Hunsmann, J. Skowronski, and F. Kirchhoff. 1997. Association of simian immunodefi ciency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat. Med. 3:860-865.
17. Khan, I.H., E.T. Sawai, E. Antonio, C.J. Weber, C.P. Mandell, P. Montbriand, and P.A. Luciw. 1998. Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J. Virol. 72:5820-5830.
18. Tokunaga, K., E. Kiyokawa, M. Nakaya, N. Otsuka, A. Kojima, T. Kurata, and M. Matsuda. 1998. Inhibition of human immunodeficiency virus type 1 virion entry by dominant-negative Hck. J. Virol. 72:6257-6259.
19. Baer, M., S.C. Williams, A. Dillner, R.C. Schwartz, and P.F. Johnson. 1998. Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages. Blood. 92:4353-4365.
20. Xiong, W., C.C. Hsieh, A.J. Kurtz, J.P. Rabek, and J. Papaconstantinou. 2001. Regulation of CCAAT/enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Res. 29: 3087-3098.
21. Henderson, A.J., and K.L. Calame. 1997. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc. Natl. Acad. Sci. USA. 94:8714-8719.
22. Ruocco, M.R., X. Chen, C. Ambrosino, E. Dragonetti, W. Liu, M. Mallardo, G. De Falco, C. Palmieri, G. Franzoso, I. Quinto, et al. 1996. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF- IL6) and NF-kappaB/ Rel transcription factors. J. Biol. Chem. 271:22479-22486.
23. Honda, Y., L. Rogers, K. Nakata, B.Y. Zhao, R. Pine, Y. Nakai, K. Kurosu, W.N. Rom, and M. Weiden. 1998. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J. Exp. Med. 188:1255-1265.
24. Weiden, M., N. Tanaka, Y. Qiao, B.Y. Zhao, Y. Honda, K. Nakata, A. Canova, D.E. Levy, W.N. Rom, and R. Pine. 2000. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J. Immunol. 165:2028-2039.
25. Hashimoto, S., I. Komuro, M. Yamada, and K.S. Akagawa. 2001. Il-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J. Immunol. 167:3619-3625.
26. Komuro, I., N. Keicho, A. Iwamoto, and K.S. Akagawa. 2001. Human alveolar macrophages and granulocyte-macrophage colony-stimulating factor-induced monocyte-derived macrophages are resistant to H2O2 via their high basal and inducible levels of catalase activity. J. Biol. Chem. 276:243610-24364.
27. Matsuda, S., K. Akagawa, M. Honda, Y. Yokota, Y. Takebe, and T. Takemori. 1995. Suppression of HIV replication in human monocyte-derived macrophages induced granulocyte/macrophage colony-stimulating factor. AIDS Res. Hum. Retroviruses. 11:1031-1038.
28. Tsunetsugu-Yokota, Y., K. Akagawa, H. Kimoto, K. Suzuki, M. Iwasaki, S. Yasuda, G. Hausser, C. Hultgren, A. Meyerhans, and T. Takemori. 1995. Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation. J. Virol. 69:4544-4547.
29. Iwama, A., M. Osawa, R. Hirasawa, N. Uchiyama, S. Kaneko, M. Onodera, K. Shibuya, A. Shibuya, C. Vinson, D.G. Tenen, and H. Nakauchi. 2002. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 195:547-558.
30. Briggs, S.D., and T.E. Smithgall. 1999. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts. J. Biol. Chem. 274:26579-26583.
31. Chiaradonna, F., L. Fontana, C. Iavarone, M.V. Carriero, G. Scholz, M.V. Barone, and M.P. Stoppelli. 1999. Urokinase receptor-dependent and - independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence. EMBO J. 18:3013-3023.
32. Akagawa, K.S., N. Takasuka, Y. Nozaki, I. Komuro, M. Azuma, M. Ueda, M. Naito, and K. Takahashi. 1996. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood. 88:4029-4039.
33. Wei, S., J.H. Liu, P.K. Epling-Burnette, A.M. Gamero, D. Ussery, E.W. Pearson, M.E. Elkabani, J.I. Diaz, and J.Y. Djeu. 1996. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J. Immunol. 157:5155-5162.
34. Adler, G. 1997. Functional NF-IL6/CCAAT enhancer-binding protein is required for tumor necrosis factor alpha-inducible expression of the granulocyte colony-stimulating factor (CSF), but not the granulocyte/macrophage CSF or interleukin 6 gene in human fibroblasts [retraction of Kiehntopf, M., F. Hermaann, and M.A. Brach. 1995. J. Exp. Med. 181:793-798]. J. Exp. Med. 186:171.
35. Berkowitz, R.D., S. Alexander, C. Bare, V. Linquist-Stepps, M. Bogan, M.E. Moreno, L. Gibson, E.D. Wieder, J. Kosek, C.A. Stoddart, and J.M. McCune. 1998. CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J. Virol. 72:10108-10117.
36. Lee, B., M. Sharron, L.J. Montaner, D. Weissman, and R.W. Doms. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA. 96:5215-5220.
37. Worgall, S., R. Connor, R.J. Kaner, E. Fenamore, K. Sheridan, R. Singh, and R.G. Crystal. 1999. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. J. Virol. 73:5865-5874.
38. Kutza, J., L. Crim, S. Feldman, M.P. Hayes, M. Gruber, J. Beeler, and K.A. Clouse. 2000. Macrophage colony-stimulating factor antagonists inhibit replication of HIV-1 in human macrophages. J. Immunol. 164:4955-4960.
39. Crowe, S.M., and A. Lopez. 1997. GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage. J. Leukoc. Biol. 62:41-48.
40. Kedzierska, K., M.A. Rainbird, A.F. Lopez, and S.M. Crowe. 1998. Effect of GM- CSF on HIV-1 replication in monocytes/macrophages in vivo and in vitro: a review. Vet. Immunol. Immunopathol. 63:111-121.
41. Galio, L., S. Briquet, and C. Vaquero. 1999. Real-time study of interactions between a composite DNA regulatory region (HIV-1 LTR NRE) and several transcription factors of nuclear extracts. Biochem. Biophys. Res. Commun. 264:6-13.
42. Descombes, P., and U. Schibler. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell. 67:569-579.
43. Ossipow, V., U.K. Laemmli, and U. Schibler. 1993. A simple method to renature DNA-binding proteins separated by SDS-polyacrylamide gel electrophoresis. Nucleic Acids Res. 21:6040-6041.
44. Calkhoven, C.F., L. Snippe, and G. Ab. 1997. Differential stimulation by CCAAT/enhancer-binding protein alpha isoforms of the estrogen-activated promoter of the very-low-density apolipoprotein II gene. Eur. J. Biochem. 249:113-120.
45. Lichtenberg, U., N. Quintrell, and J.M. Bishop. 1992. Human protein-tyrosine kinase gene HCK: expression and structural analysis of the promoter region. Oncogene. 7:849-858.
46. Hauses, M., R.R. Tonjes, and M. Grez. 1998. The transcription factor Sp1 regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region. J. Biol. Chem. 273:31844-31852.
47. Radzun, H.J., H. Kreipe, K. Heidom, and M.R. Parwaresch. 1988. Modulation of c-fms proto-oncogene expression in human blood monocytes and macrophages. J. Leukoc. Biol. 44:198-204.
48. Krombach, F., J.T. Gerlach, C. Padovan, A. Burges, J. Behr, T. Beinert, and C. Vogelmeier. 1996. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory lung disease. Eur. Respir. J. 9:984-991.
49. Hoshino, Y., K. Nakata, S. Hoshino, Y. Honda, D.B. Tse, T. Shioda, W.N. Pom, and M. Weiden. 2002. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J. Exp. Med. 195:495-505.